W7N-14860-92380
3 vaccinations
3 coded responses
29 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 117 / NY
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
-
2021-04-23
Survey response — day 21, dose 2MedDRA: Migraine, Pain in extremity, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Severe pain in legs. Migraine. · Healthcare visit (other): Leg dopplerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
- 2021-10-01
-
2021-10-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Menstruation irregular — Feeling: Fair · Fatigue or tiredness, DiarrheaFree text: Changes in mensesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-09
- 2021-10-18
- 2021-10-25
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2022-01-01
- 2022-04-04
- 2022-04-06
-
2022-10-04
Survey response — 12 months, dose 3MedDRA: Haemorrhoid operation, Hospitalisation, Inflammation, Surgery, Swelling — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Inflammation and rare excessive swelling following hemorrhoidectomy requiring additional surgery and hospitalization.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-10-05
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-05
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-23 | Successful 2022-10-05 |
Participant prefers to complete VAERS report online |
| 2022-10-04 | Successful 2022-10-05 |
Participant prefers to complete VAERS report online |
Free text
Release 7 — day 21, dose 2
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Changes in menses
Release 12 — 12 months, dose 3
Symptoms: Inflammation and rare excessive swelling following hemorrhoidectomy requiring additional surgery and hospitalization.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Haemorrhoid operation | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Surgery | · | · | ✓ |
| SD | Swelling | · | · | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release